Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
Renal Failure|January 1, 1991
Nephrotoxicity of an ellipticine derivative (N2-methyl-9-hydroxyellipticinium acetate) in rat: a defect of urinary concentrating abilityN Thomas, B Moulin, G Raguenez-Viotte, et al.Journal of Neuroscience Research|May 23, 2000
Phospholipid incorporation and metabolic conversion of n-3 polyunsaturated fatty acids in the Y79 retinoblastoma cell lineB Goustard-Langelier, J M Alessandri, G Raguenez, et al.Oncogene|September 26, 2001
Cloning and characterization of a novel transcription factor involved in cellular proliferation arrest: PATFP Crisanti, G Raguenez, C Blancher, et al.Nucleic Acids Research|February 11, 1995
Hierarchy and positive/negative interplays of the hepatocyte nuclear factors HNF-1, -3 and -4 in the liver-specific enhancer for the human alpha-1-microglobulin/bikunin precursorP Rouet, G Raguenez, F Tronche, et al.Bulletin Du Cancer|January 1, 1984
[In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests]J Bénard, G RiouBulletin Du Cancer|March 1, 1997
[Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis]A Chassevent, J BénardInternational Journal of Cancer|February 7, 1997
Pleiotropic over-expression of multidrug-resistance-related genes is correlated to MYCN and max mRNA accumulation during tumour progression in the IGR-N-91 human neuroblastoma modelD Cappellen, J BénardProgress in Clinical and Biological Research|January 1, 1994
Retinoic acid and forskolin activate the human MDR1 gene promoter in differentiated neuroblastsE Ferrandis, J BénardPresse Medicale (Paris, France : 1983)|November 16, 1996
[Resistance to anticancer drugs]J Bénard, O RixeInternational Journal of Cancer|July 30, 1993
Activation of the human MDR1 gene promoter in differentiated neuroblastsE Ferrandis, J BénardPageof 11